ENTITY
Mezzion Pharma

Mezzion Pharma (140410 KS)

21
Analysis
Health Care • South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
Exchange Announcement • 04 Aug 2026 20:03

Designation of overheated short-selling issues (applied by a restriction on short-selling)

Exchange Announcement • 21 May 2026 17:39

Lawsuit (Charging More Than Certain Amount)

Exchange Announcement • 12 May 2026 15:19

Results of issuance(Voluntary Disclosure)(ì œ6회차 CB)

Exchange Announcement • 17 Apr 2026 14:48

Settlement of Lawsuit (Charging More Than Certain Amount)

Exchange Announcement • 30 Mar 2026 17:24

Outcomes of Annual Meeting of Shareholders

x